Skip to content
healthcare.dev

RELEUKO

NDC 70121-1569, Filgrastim, injection, solution, from Amneal Pharmaceuticals LLC.

Product NDC
70121-1569
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761082
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1569 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM300 ug/mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
70121-1569-77012115690710 VIAL in 1 PACKAGE (70121-1569-7) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/74e1ec6e-1630-4654-895c-2bd355f939e7
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70121-1569

Use it

Look up 70121-1569 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70121-1569 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70121-1569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.